Ceylon Hospitals PLC (COSE:CHL.N0000)
Sri Lanka · Delayed Price · Currency is LKR 0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Ceylon Hospitals Income Statement
Financials in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 10,941 | 9,751 | 9,153 | 7,905 | 7,841 | 5,546 | |
Revenue Growth (YoY) | 17.44% | 6.53% | 15.78% | 0.82% | 41.39% | -7.20% |
Cost of Revenue | 4,219 | 3,928 | 4,014 | 3,095 | 2,880 | 2,052 |
Gross Profit | 6,721 | 5,822 | 5,139 | 4,811 | 4,961 | 3,494 |
Selling, General & Admin | 4,148 | 3,674 | 3,302 | 2,878 | 2,854 | 2,337 |
Other Operating Expenses | 1,340 | 1,243 | 1,254 | 1,020 | 717.5 | 521.87 |
Operating Expenses | 5,488 | 4,917 | 4,556 | 3,898 | 3,571 | 2,859 |
Operating Income | 1,234 | 905.23 | 582.91 | 913.18 | 1,389 | 634.5 |
Interest Expense | -194.1 | -246.5 | -137.83 | -83.35 | -76.56 | -93.01 |
Interest & Investment Income | 32.88 | 51.14 | 99.66 | 207.25 | 81.82 | 50.31 |
Earnings From Equity Investments | - | - | - | - | 11.72 | 102.87 |
Currency Exchange Gain (Loss) | -0.72 | -0.72 | - | - | - | - |
Other Non Operating Income (Expenses) | -4.3 | -4.3 | -6.84 | -4.54 | -4.01 | -3.67 |
EBT Excluding Unusual Items | 1,067 | 704.85 | 537.9 | 1,033 | 1,402 | 691 |
Gain (Loss) on Sale of Investments | 216.97 | 216.97 | 113.44 | 27.8 | -32.92 | - |
Gain (Loss) on Sale of Assets | 36.1 | 36.1 | 6.43 | - | 5.2 | 5.34 |
Other Unusual Items | - | - | 1.11 | - | 14.45 | - |
Pretax Income | 1,320 | 957.92 | 658.89 | 1,060 | 1,389 | 696.34 |
Income Tax Expense | 349.92 | 231.91 | 205.07 | 408.65 | 279.38 | 96.08 |
Earnings From Continuing Operations | 970.51 | 726.01 | 453.81 | 651.67 | 1,110 | 600.26 |
Minority Interest in Earnings | -81.66 | -73.41 | -36.62 | -79.84 | -127.2 | -39.91 |
Net Income | 888.85 | 652.6 | 417.19 | 571.83 | 982.32 | 560.35 |
Net Income to Common | 888.85 | 652.6 | 417.19 | 571.83 | 982.32 | 560.35 |
Net Income Growth | 30.56% | 56.43% | -27.04% | -41.79% | 75.31% | 38.95% |
Shares Outstanding (Basic) | 162 | 159 | 144 | 136 | 135 | 135 |
Shares Outstanding (Diluted) | 162 | 159 | 144 | 136 | 135 | 135 |
Shares Change (YoY) | 1.49% | 10.73% | 6.23% | 0.02% | - | - |
EPS (Basic) | 5.50 | 4.09 | 2.90 | 4.22 | 7.25 | 4.14 |
EPS (Diluted) | 5.50 | 4.09 | 2.90 | 4.22 | 7.25 | 4.14 |
EPS Growth | 28.65% | 41.26% | -31.32% | -41.80% | 75.31% | 38.95% |
Free Cash Flow | 953.08 | 843.18 | -60.01 | -2,110 | 395.27 | 879.95 |
Free Cash Flow Per Share | 5.89 | 5.29 | -0.42 | -15.57 | 2.92 | 6.50 |
Dividend Per Share | 1.000 | 1.000 | 0.500 | 0.575 | 1.250 | 0.800 |
Dividend Growth | 100.00% | 100.00% | -13.04% | -54.00% | 56.25% | 45.45% |
Gross Margin | 61.43% | 59.71% | 56.14% | 60.86% | 63.27% | 63.00% |
Operating Margin | 11.28% | 9.28% | 6.37% | 11.55% | 17.72% | 11.44% |
Profit Margin | 8.12% | 6.69% | 4.56% | 7.23% | 12.53% | 10.11% |
Free Cash Flow Margin | 8.71% | 8.65% | -0.66% | -26.70% | 5.04% | 15.87% |
EBITDA | 1,838 | 1,416 | 1,025 | 1,302 | 1,729 | 989.24 |
EBITDA Margin | 16.80% | 14.53% | 11.20% | 16.48% | 22.05% | 17.84% |
D&A For EBITDA | 604.69 | 511.15 | 442.58 | 389.26 | 339.85 | 354.74 |
EBIT | 1,234 | 905.23 | 582.91 | 913.18 | 1,389 | 634.5 |
EBIT Margin | 11.28% | 9.28% | 6.37% | 11.55% | 17.72% | 11.44% |
Effective Tax Rate | 26.50% | 24.21% | 31.12% | 38.54% | 20.11% | 13.80% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.